{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"386"},{"groupId":"OG001","value":"410"}],"title":"received at least 75% of the prescribed chemotherapy"},{"measurements":[{"groupId":"OG000","value":"74"},{"groupId":"OG001","value":"31"}],"title":"received less than 75 % of the prescribed neoadjuvant treatment"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"460"},{"groupId":"OG001","value":"441"}],"units":"Participants"}],"description":"Number of patients in the experimental arm receiving 5 fractions of x 5 Gy (5x5Gy) radiotherapy followed by at least 75% of the prescribed chemotherapy.\n\nIn the standard arm receiving the prescribed chemoradiotherapy.","groups":[{"description":"Experimental group B: 5x5Gy -\\> CAPOX -\\> Surgery","id":"OG000","title":"B: 5x5Gy -> CAPOX -> Surgery"},{"description":"Control group A: 5 Weeks Chemoradiation -\\> Surgery","id":"OG001","title":"A: 5 Weeks Chemoradiation -> Surgery"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"901 of the 920 patients were evaluable","reportingStatus":"POSTED","timeFrame":"30 days after neoadjuvant treatment","title":"Number of Patients Completing the Prescribe Neo-adjuvant Treatment Dose","type":"SECONDARY","unitOfMeasure":"Participants"}